Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survival in patients with glioblastoma receiving valganciclovir.
Söderberg-Nauclér C, Rahbar A, Stragliotto G. Söderberg-Nauclér C, et al. Among authors: stragliotto g. N Engl J Med. 2013 Sep 5;369(10):985-6. doi: 10.1056/NEJMc1302145. N Engl J Med. 2013. PMID: 24004141 No abstract available.
Valganciclovir in patients with glioblastoma.
Söderberg-Nauclér C, Peredo I, Stragliotto G. Söderberg-Nauclér C, et al. Among authors: stragliotto g. N Engl J Med. 2013 Nov 21;369(21):2066-7. doi: 10.1056/NEJMc1312413. N Engl J Med. 2013. PMID: 24256396 No abstract available.
Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.
Stragliotto G, Rahbar A, Solberg NW, Lilja A, Taher C, Orrego A, Bjurman B, Tammik C, Skarman P, Peredo I, Söderberg-Nauclér C. Stragliotto G, et al. Int J Cancer. 2013 Sep 1;133(5):1204-13. doi: 10.1002/ijc.28111. Epub 2013 Mar 13. Int J Cancer. 2013. PMID: 23404447 Free article. Clinical Trial.
Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir.
Söderberg-Naucler C, Peredo I, Rahbar A, Hansson F, Nordlund A, Stragliotto G. Söderberg-Naucler C, et al. Among authors: stragliotto g. Int J Cancer. 2014 Jul 1;135(1):248-9. doi: 10.1002/ijc.28663. Epub 2014 Jan 6. Int J Cancer. 2014. PMID: 24338548 Free article. No abstract available.
Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
Vasaikar S, Tsipras G, Landázuri N, Costa H, Wilhelmi V, Scicluna P, Cui HL, Mohammad AA, Davoudi B, Shang M, Ananthaseshan S, Strååt K, Stragliotto G, Rahbar A, Wong KT, Tegner J, Yaiw KC, Söderberg-Naucler C. Vasaikar S, et al. Among authors: stragliotto g. BMC Cancer. 2018 Feb 6;18(1):154. doi: 10.1186/s12885-018-4012-7. BMC Cancer. 2018. PMID: 29409474 Free PMC article.
Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact.
Fornara O, Bartek J Jr, Rahbar A, Odeberg J, Khan Z, Peredo I, Hamerlik P, Bartek J, Stragliotto G, Landázuri N, Söderberg-Nauclér C. Fornara O, et al. Among authors: stragliotto g. Cell Death Differ. 2016 Feb;23(2):261-9. doi: 10.1038/cdd.2015.91. Epub 2015 Jul 3. Cell Death Differ. 2016. PMID: 26138445 Free PMC article.
34 results